Alix de Chevigny
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Alix de Chevigny has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Catherine Eckert
ER8, Université Pierre et Marie Curie, Paris, France
2 shared publications A. Emirian
Laboratoire de Bactériologie, Virologie, Hygiène, Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris, Créteil, France
1 shared publicationA. Petit
Laboratoire associé « Clostridium difficile », Hôpital Saint Antoine, Assistance Publique-Hôpitaux de Paris, France
1 shared publication- Adeline Champrigaud
Innovation and Transformation Department Information Systems Directorate Paris Saint-Joseph Hospital Group Paris France
1 shared publication - Alban Le Monnier
Service de microbiologie clinique, groupe hospitalier Paris Saint-Joseph, 75014 Paris, France
1 shared publication Amandine Petit
Laboratoire Clostridium difficile associé au CNR des bactéries anaérobies et du botulisme, 75012 Paris, France; Groupe de recherche clinique n(o) 2 EPIDIFF, université Pierre-et-Marie-Curie, site Saint-Antoine, 75012 Paris, France
1 shared publication
Latest Publications
- Open Access
- 11 October 2022
- Published by JMIR Publications Inc. in JMIR Human Factors
- Vol. 9 (4) , e39102
Answering Hospital Caregivers’ Questions at Any Time: Proof-of-Concept Study of an Artificial Intelligence–Based Chatbot in a French Hospital
Background: Access to accurate information in health care is a key point for caregivers to avoid medication errors, especially with the reorganization of staff and drug circuits during health crises such as the COVID‑19 pandemic. It is, therefore, the role of the hospital pharmacy to answer caregivers’ questions. Some may require the expertise of a pharmacist, some should be answered by pharmacy technicians, but others are simple and redundant, and automated responses may be provided. Objective: We aimed at developing and implementing a chatbot to answer questions from hospital caregivers about drugs and pharmacy organization 24 hours a day and to evaluate this tool. Methods: The ADDIE (Analysis, Design, Development, Implementation, and Evaluation) model was used by a multiprofessional team composed of 3 hospital pharmacists, 2 members of the Innovation and Transformation Department, and the IT service provider. Based on an analysis of the caregivers’ needs about drugs and pharmacy organization, we designed and developed a chatbot. The tool was then evaluated before its implementation into the hospital intranet. Its relevance and conversations with testers were monitored via the IT provider’s back office. Results: Needs analysis with 5 hospital pharmacists and 33 caregivers from 5 health services allowed us to identify 7 themes about drugs and pharmacy organization (such as opening hours and specific prescriptions). After a year of chatbot design and development, the test version obtained good evaluation scores: its speed was rated 8.2 out of 10, usability 8.1 out of 10, and appearance 7.5 out of 10. Testers were generally satisfied (70%) and were hoping for the content to be enhanced. Conclusions: The chatbot seems to be a relevant tool for hospital caregivers, helping them obtain reliable and verified information they need on drugs and pharmacy organization. In the context of significant mobility of nursing staff during the health crisis due to the COVID-19 pandemic, the chatbot could be a suitable tool for transmitting relevant information related to drug circuits or specific procedures. To our knowledge, this is the first time that such a tool has been designed for caregivers. Its development further continued by means of tests conducted with other users such as pharmacy technicians and via the integration of additional data before the implementation on the 2 hospital sites.
- 11 October 2022
- Published by JMIR Publications Inc. in JMIR Human Factors
- Vol. 9 (4) , e39102
Open AccessAnswering Hospital Caregivers’ Questions at Any Time: Proof-of-Concept Study of an Artificial Intelligence–Based Chatbot in a French Hospital
Background: Access to accurate information in health care is a key point for caregivers to avoid medication errors, especially with the reorganization of staff and drug circuits during health crises such as the COVID‑19 pandemic. It is, therefore, the role of the hospital pharmacy to answer caregivers’ questions. Some may require the expertise of a pharmacist, some should be answered by pharmacy technicians, but others are simple and redundant, and automated responses may be provided. Objective: We aimed at developing and implementing a chatbot to answer questions from hospital caregivers about drugs and pharmacy organization 24 hours a day and to evaluate this tool. Methods: The ADDIE (Analysis, Design, Development, Implementation, and Evaluation) model was used by a multiprofessional team composed of 3 hospital pharmacists, 2 members of the Innovation and Transformation Department, and the IT service provider. Based on an analysis of the caregivers’ needs about drugs and pharmacy organization, we designed and developed a chatbot. The tool was then evaluated before its implementation into the hospital intranet. Its relevance and conversations with testers were monitored via the IT provider’s back office. Results: Needs analysis with 5 hospital pharmacists and 33 caregivers from 5 health services allowed us to identify 7 themes about drugs and pharmacy organization (such as opening hours and specific prescriptions). After a year of chatbot design and development, the test version obtained good evaluation scores: its speed was rated 8.2 out of 10, usability 8.1 out of 10, and appearance 7.5 out of 10. Testers were generally satisfied (70%) and were hoping for the content to be enhanced. Conclusions: The chatbot seems to be a relevant tool for hospital caregivers, helping them obtain reliable and verified information they need on drugs and pharmacy organization. In the context of significant mobility of nursing staff during the health crisis due to the COVID-19 pandemic, the chatbot could be a suitable tool for transmitting relevant information related to drug circuits or specific procedures. To our knowledge, this is the first time that such a tool has been designed for caregivers. Its development further continued by means of tests conducted with other users such as pharmacy technicians and via the integration of additional data before the implementation on the 2 hospital sites.
- 1 April 2015
- Published by Elsevier in La Presse Médicale
- Vol. 44 (4) , e75-e83
Prévalence des infections à Clostridium difficile chez les patients hospitalisés avec une diarrhée : résultats d’une étude française prospective multicentrique
- 1 April 2015
- Published by Elsevier in La Presse Médicale
- Vol. 44 (4) , e75-e83
Prévalence des infections à Clostridium difficile chez les patients hospitalisés avec une diarrhée : résultats d’une étude française prospective multicentrique
- Open Access
- 1 January 2015
- Published by Elsevier in New Microbes and New Infections
- Vol. 3, 12-17
Prevalence and pathogenicity of binary toxin–positive Clostridium difficile strains that do not produce toxins A and B
- 1 January 2015
- Published by Elsevier in New Microbes and New Infections
- Vol. 3, 12-17
Open AccessPrevalence and pathogenicity of binary toxin–positive Clostridium difficile strains that do not produce toxins A and B